1. Home
  2. VRCA vs NRDY Comparison

VRCA vs NRDY Comparison

Compare VRCA & NRDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$6.15

Market Cap

137.3M

Sector

Health Care

ML Signal

HOLD

Logo Nerdy Inc.

NRDY

Nerdy Inc.

HOLD

Current Price

$0.81

Market Cap

114.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRCA
NRDY
Founded
2013
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
137.3M
114.0M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
VRCA
NRDY
Price
$6.15
$0.81
Analyst Decision
Buy
Hold
Analyst Count
2
1
Target Price
$17.00
$1.00
AVG Volume (30 Days)
83.8K
400.9K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
13.16
EPS
N/A
N/A
Revenue
$35,577,000.00
N/A
Revenue This Year
N/A
$4.88
Revenue Next Year
$94.44
$10.03
P/E Ratio
N/A
N/A
Revenue Growth
370.22
N/A
52 Week Low
$0.49
$0.75
52 Week High
$9.82
$1.90

Technical Indicators

Market Signals
Indicator
VRCA
NRDY
Relative Strength Index (RSI) 45.71 42.55
Support Level $5.13 $0.77
Resistance Level $6.40 $0.97
Average True Range (ATR) 0.73 0.05
MACD -0.20 -0.01
Stochastic Oscillator 21.52 27.81

Price Performance

Historical Comparison
VRCA
NRDY

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

About NRDY Nerdy Inc.

Nerdy Inc operate a next-generation live tutoring and intervention platform that leverages the power of human expertise with Developed artificial intelligence (AI) to personalize learning, accelerate student achievement, and empower educators. The company's proprietary platform leverages technology, including AI, to connect learners with instructors across a wide range of subjects and formats, including subscription-based learning, one-on-one instruction, small group tutoring, large-format classes, and assessments. Its flagship business operates under the Varsity Tutors brand. The company's offerings are available directly to students and consumers, as well as through schools and other institutions.

Share on Social Networks: